OTC, supplements & other. Every registered pack in the UAE with published prices, agents and manufacturers; the price spread between brands; the same medicine in India, the US and the EU; and same‑class alternatives.
Unit price to public, same form and strength, registered brands only. Green = cheapest. The spread is the gap a class‑level tender or formulary switch can usually close.
India: India brand MRP (median of 4) ₹18.50 ($0.220) per tablet at 250mg. US prices are not published by FDA; EU prices are national. Ask us for a landed‑cost benchmark.
₹13.70–37.30 per unit across 8 priced packs. MRP as printed on pack (indicative, open dataset 2024); combinations listed after single‑ingredient brands. Showing 8 of 8.
| Brand | Manufacturer | Strength | Pack | MRP ₹ | ₹ / unit |
|---|---|---|---|---|---|
| Ostivestin 250mg Tablet | Zydus Cadila | 250mg | strip of 10 tablets | ₹137.00 | ₹13.70 |
| Corvestin 250mg Tablet | Corona Remedies Pvt Ltd | 250mg | strip of 10 tablets | ₹175.00 | ₹17.50 |
| Flavestin 250mg Tablet | Indoco Remedies Ltd | 250mg | strip of 10 tablets | ₹185.00 | ₹18.50 |
| Dolestin 250 Tablet | Zuventus Healthcare Ltd | 250mg | strip of 10 tablets | ₹192.00 | ₹19.20 |
| Ostivestin 500mg Tablet | Zydus Cadila | 500mg | strip of 10 tablets | ₹255.00 | ₹25.50 |
| Uniwin Tablet | Hetero Drugs Ltd | 500mg | strip of 10 tablets | ₹330.00 | ₹33.00 |
| Dolestin 500 Tablet | Zuventus Healthcare Ltd | 500mg | strip of 10 tablets | ₹373.00 | ₹37.30 |
| Dolsten 500mg Tablet | Zuventus Healthcare Ltd | 500mg | strip of 10 tablets | ₹373.00 | ₹37.30 |
Not yet classified.
None are Active on the UAE register at this release.
No published UAE price at this release.
No matching‑strength India reference price is available for a per‑unit comparison.
See the register tab.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Data: DoH Abu Dhabi Shafafiya drug list (2 Nov 2026); FDA NDC Directory and Orange Book (Sept–Nov 2026); NPPA and PMBI Jan Aushadhi (Nov 2026); EMA (Nov 2026); WHO ATC/DDD 2026; Consulting Wallah class repository. For information only; verify with the regulator before purchase or dispensing. No prescribing advice. © Consulting Wallah — CC BY‑NC‑ND; bulk extraction not permitted.